• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞诱导卵巢癌 T 细胞免疫麻痹的机制。

Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.

机构信息

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Department of Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

出版信息

Cancer Immunol Res. 2021 Jul;9(7):790-810. doi: 10.1158/2326-6066.CIR-20-0922. Epub 2021 May 14.

DOI:
10.1158/2326-6066.CIR-20-0922
PMID:33990375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8287091/
Abstract

T-cell activation and expansion in the tumor microenvironment (TME) are critical for antitumor immunity. Neutrophils in the TME acquire a complement-dependent T-cell suppressor phenotype that is characterized by inhibition of T-cell proliferation and activation through mechanisms distinct from those of myeloid-derived suppressor cells. In this study, we used ascites fluid supernatants (ASC) from patients with ovarian cancer as an authentic component of the TME to evaluate the effects of ASC on neutrophil function and mechanisms for neutrophil-driven immune suppression. ASC prolonged neutrophil life span, decreased neutrophil density, and induced nuclear hypersegmentation. Mass cytometry analysis showed that ASC induced 15 distinct neutrophil clusters. ASC stimulated complement deposition and signaling in neutrophils, resulting in surface mobilization of granule constituents, including NADPH oxidase. NADPH oxidase activation and phosphatidylserine signaling were required for neutrophil suppressor function, although we did not observe a direct role of extracellular reactive oxygen species in inhibiting T-cell proliferation. Postoperative surgical drainage fluid also induced a complement-dependent neutrophil suppressor phenotype, pointing to this effect as a general response to injury. Like circulating lymphocytes, ASC-activated neutrophils caused complement-dependent suppression of tumor-associated lymphocytes. ASC-activated neutrophils adhered to T cells and caused trogocytosis of T-cell membranes. These injury and signaling cues resulted in T-cell immunoparalysis characterized by impaired NFAT translocation, IL2 production, glucose uptake, mitochondrial function, and mTOR activation. Our results demonstrate that complement-dependent priming of neutrophil effector functions in the TME induces a T-cell nonresponsiveness distinct from established checkpoint pathways and identify targets for immunotherapy.

摘要

T 细胞在肿瘤微环境(TME)中的激活和扩增对于抗肿瘤免疫至关重要。TME 中的中性粒细胞获得一种补体依赖性 T 细胞抑制表型,其特征是通过与髓系来源的抑制细胞不同的机制抑制 T 细胞增殖和激活。在这项研究中,我们使用卵巢癌患者的腹水上清液(ASC)作为 TME 的真实成分,来评估 ASC 对中性粒细胞功能的影响及其驱动免疫抑制的机制。ASC 延长了中性粒细胞的寿命,降低了中性粒细胞的密度,并诱导核过度分裂。质谱细胞术分析显示,ASC 诱导了 15 个不同的中性粒细胞簇。ASC 刺激中性粒细胞中补体的沉积和信号转导,导致颗粒成分(包括 NADPH 氧化酶)的表面动员。NADPH 氧化酶的激活和磷脂酰丝氨酸信号转导是中性粒细胞抑制功能所必需的,尽管我们没有观察到细胞外活性氧在抑制 T 细胞增殖中的直接作用。术后手术引流液也诱导了一种补体依赖性中性粒细胞抑制表型,这表明这种效应是对损伤的一般反应。与循环淋巴细胞一样,ASC 激活的中性粒细胞导致肿瘤相关淋巴细胞的补体依赖性抑制。ASC 激活的中性粒细胞黏附于 T 细胞并导致 T 细胞膜的 trogocytosis。这些损伤和信号提示导致 T 细胞免疫麻痹,其特征为 NFAT 易位、IL2 产生、葡萄糖摄取、线粒体功能和 mTOR 激活受损。我们的结果表明,TME 中补体依赖性中性粒细胞效应功能的启动诱导了一种与已建立的检查点途径不同的 T 细胞无反应性,并确定了免疫治疗的靶点。

相似文献

1
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.中性粒细胞诱导卵巢癌 T 细胞免疫麻痹的机制。
Cancer Immunol Res. 2021 Jul;9(7):790-810. doi: 10.1158/2326-6066.CIR-20-0922. Epub 2021 May 14.
2
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.成熟中性粒细胞在卵巢癌微环境中抑制 T 细胞免疫。
JCI Insight. 2019 Mar 7;4(5). doi: 10.1172/jci.insight.122311.
3
Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.KRAS 诱导的卵巢癌细胞激活腹腔中性粒细胞通过调节适应性免疫发挥抗肿瘤作用。
Int J Oncol. 2018 Oct;53(4):1580-1590. doi: 10.3892/ijo.2018.4504. Epub 2018 Jul 26.
4
Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.中性粒细胞和粒细胞髓系来源的抑制性细胞介导的 T 细胞抑制显著导致常见可变免疫缺陷疾病中的免疫失调。
J Immunol. 2019 Jan 1;202(1):93-104. doi: 10.4049/jimmunol.1800102. Epub 2018 Nov 28.
5
Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.活化的中性粒细胞发挥髓源性抑制细胞活性,损害 T 细胞,使其无法修复。
Blood Adv. 2019 Nov 26;3(22):3562-3574. doi: 10.1182/bloodadvances.2019031609.
6
Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells.甲酰肽通过激活抗肿瘤中性粒细胞和 T 细胞增强癌症免疫疗法。
Biomed Pharmacother. 2024 Jun;175:116670. doi: 10.1016/j.biopha.2024.116670. Epub 2024 Apr 30.
7
Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils.人中性粒细胞的氧化爆发对淋巴细胞代谢转换的抑制作用。
Clin Sci (Lond). 2015 Sep;129(6):489-504. doi: 10.1042/CS20140852. Epub 2015 May 7.
8
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes.精氨酸酶1的抑制可释放人中性粒细胞强大的T细胞免疫刺激活性。
Front Immunol. 2021 Feb 26;11:617699. doi: 10.3389/fimmu.2020.617699. eCollection 2020.
9
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.靶向肿瘤微环境中的髓样细胞可增强小鼠上皮性卵巢癌疫苗的疗效。
Oncotarget. 2015 May 10;6(13):11310-26. doi: 10.18632/oncotarget.3597.
10
Neutrophils Lose the Capacity to Suppress T Cell Proliferation Upon Migration Towards Inflamed Joints in Juvenile Idiopathic Arthritis.中性粒细胞在向幼年特发性关节炎炎症关节迁移时失去抑制 T 细胞增殖的能力。
Front Immunol. 2022 Jan 13;12:795260. doi: 10.3389/fimmu.2021.795260. eCollection 2021.

引用本文的文献

1
Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-Seq.利用单细胞RNA测序对胰腺导管腺癌中T细胞耗竭和癌症生物标志物的新见解
Biology (Basel). 2025 Aug 7;14(8):1015. doi: 10.3390/biology14081015.
2
The silent protectors: how neutrophils influence female fertility during cancer treatment - a narrative review.沉默的守护者:中性粒细胞在癌症治疗期间如何影响女性生育能力——一篇叙述性综述
Ann Med Surg (Lond). 2025 Jul 16;87(8):5062-5069. doi: 10.1097/MS9.0000000000003526. eCollection 2025 Aug.
3
Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer.

本文引用的文献

1
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice.分析癌症患者和荷瘤小鼠中的经典中性粒细胞和多形核髓系来源的抑制细胞。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20201803.
2
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.在髓系细胞多样性不断增加的时代中的髓源性抑制细胞。
Nat Rev Immunol. 2021 Aug;21(8):485-498. doi: 10.1038/s41577-020-00490-y. Epub 2021 Feb 1.
3
Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
三级淋巴结构:探索改善卵巢癌免疫治疗的机会
Front Immunol. 2025 May 22;16:1473969. doi: 10.3389/fimmu.2025.1473969. eCollection 2025.
4
Immune Cell Interplay in the Fight Against GBM.免疫细胞在对抗胶质母细胞瘤中的相互作用
Cancers (Basel). 2025 Feb 26;17(5):817. doi: 10.3390/cancers17050817.
5
The sentinel against brain injury post-subarachnoid hemorrhage: efferocytosis of erythrocytes by leptomeningeal lymphatic endothelial cells.蛛网膜下腔出血后脑损伤的哨兵:软脑膜淋巴内皮细胞对红细胞的胞葬作用
Theranostics. 2025 Jan 20;15(6):2487-2509. doi: 10.7150/thno.103701. eCollection 2025.
6
The success of the tumor immunotherapy: neutrophils from bench to beside.肿瘤免疫疗法的成功:从中台到床边的中性粒细胞
Front Immunol. 2025 Jan 24;16:1524038. doi: 10.3389/fimmu.2025.1524038. eCollection 2025.
7
Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer.胶原蛋白1A1作为卵巢癌临床特征和免疫微环境的新解码因子。
Front Immunol. 2025 Jan 8;15:1496090. doi: 10.3389/fimmu.2024.1496090. eCollection 2024.
8
Myeloid cells meet CD8 T cell exhaustion in cancer: What, why and how.髓系细胞与癌症中的CD8 T细胞耗竭:是什么、为什么以及如何发生。
Chin J Cancer Res. 2024 Dec 30;36(6):616-651. doi: 10.21147/j.issn.1000-9604.2024.06.04.
9
Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer.血清补体激活、中性粒细胞胞外诱捕网及细胞外DNA在新诊断上皮性卵巢癌中的预后意义
Gynecol Oncol. 2025 Feb;193:49-57. doi: 10.1016/j.ygyno.2024.12.006. Epub 2025 Jan 6.
10
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition.评估S100A8/A9和中性粒细胞作为免疫检查点抑制治疗下转移性黑色素瘤患者预后标志物的情况。
Transl Oncol. 2025 Feb;52:102224. doi: 10.1016/j.tranon.2024.102224. Epub 2024 Dec 18.
调理素在由补体失调引起的溶血性贫血中红细胞溶解和内皮细胞补体激活中是关键因子。
Front Immunol. 2020 Jul 22;11:1460. doi: 10.3389/fimmu.2020.01460. eCollection 2020.
4
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25.中性粒细胞胞外诱捕网的 DNA 通过 CCDC25 促进癌症转移。
Nature. 2020 Jul;583(7814):133-138. doi: 10.1038/s41586-020-2394-6. Epub 2020 Jun 11.
5
Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.活化的中性粒细胞发挥髓源性抑制细胞活性,损害 T 细胞,使其无法修复。
Blood Adv. 2019 Nov 26;3(22):3562-3574. doi: 10.1182/bloodadvances.2019031609.
6
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs.鉴定癌症中粒细胞样单核细胞前体细胞作为 PMN-MDSC 积累的机制。
J Exp Med. 2019 Sep 2;216(9):2150-2169. doi: 10.1084/jem.20181952. Epub 2019 Jun 25.
7
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.帕博利珠单抗治疗晚期复发性卵巢癌患者的抗肿瘤活性和安全性:来自 II 期 KEYNOTE-100 研究的结果。
Ann Oncol. 2019 Jul 1;30(7):1080-1087. doi: 10.1093/annonc/mdz135.
8
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.小分子因子 B 抑制剂用于治疗补体介导的疾病。
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7926-7931. doi: 10.1073/pnas.1820892116. Epub 2019 Mar 29.
9
Neutrophil Degranulation, Plasticity, and Cancer Metastasis.中性粒细胞脱颗粒作用、可塑性和癌症转移。
Trends Immunol. 2019 Mar;40(3):228-242. doi: 10.1016/j.it.2019.01.006. Epub 2019 Feb 15.
10
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.成熟中性粒细胞在卵巢癌微环境中抑制 T 细胞免疫。
JCI Insight. 2019 Mar 7;4(5). doi: 10.1172/jci.insight.122311.